查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1696285

全球人工智慧影像诊断市场 - 2025 至 2033 年

Global AI-Powered Imaging Diagnostics Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球人工智慧影像诊断市场规模达到 16.1 亿美元，预计到 2033 年将达到 97.3 亿美元，2025-2033 年预测期间的复合年增长率为 22.3%。

人工智慧影像诊断是指使用机器学习 (ML)、深度学习 (DL) 和电脑视觉等人工智慧 (AI) 技术来分析、解释和增强医学影像资料，以辅助诊断各种医疗状况。该技术采用先进的演算法处理医学影像，如X光、CT扫描、MRI、乳房X光检查、超音波和其他影像方式，以检测模式、识别异常并做出诊断预测，通常比传统方法具有更高的准确性和速度。

市场动态：

驱动因素与约束因素

诊断准确性和效率的提高显着推动了人工智慧成像诊断市场的成长

人工智慧系统用于在乳房X光检查中检测乳癌，其准确度与经验丰富的放射科医生相当甚至超过他们。透过减少假阳性和假阴性的数量，人工智慧可以帮助放射科医生提供更准确的诊断，这对患者的治疗结果至关重要。人工智慧系统识别了更多的癌症并减少了假阳性，从而改善了整体诊断过程。因此，影像诊断领域的主要参与者都专注于人工智慧影像诊断。

例如，2025年1月，全球医疗技术领导者荷兰皇家飞利浦推出了支援人工智慧的CT 5300。飞利浦CT 5300系统配备先进的人工智慧功能，专为诊断、介入手术和筛检而设计。灵活的X光CT系统提高了诊断信心、简化了工作流程效率、并最大限度地延长了系统正常运作时间，有助于改善病患的治疗效果和部门的工作效率。

除了提高诊断准确性之外，人工智慧成像工具还显着提高了诊断过程的效率。人工智慧可以快速处理医学影像，比人类放射科医生更快地提供结果。透过减少等待时间、提高患者吞吐量以及优化繁忙的临床环境中的工作流程，效率的提高使医疗保健系统受益。

网路安全和资料安全风险阻碍市场成长

随着人工智慧成像诊断市场持续成长，人们对网路安全和资料安全的担忧日益加剧，这可能会阻碍这些技术的广泛应用和发展。这些风险尤其重要，因为人工智慧诊断工具严重依赖大量敏感患者资料的收集、储存和分析，包括医学影像、诊断结果和个人健康资讯。

人工智慧成像诊断系统依赖大量的医学影像资料集，这些资料集通常储存在云端环境或医疗保健资讯系统中。这些系统在实现强大的人工智慧功能的同时，也带来了资料外洩和未经授权存取的严重漏洞。此次网路攻击洩漏了使用人工智慧成像诊断工具的医疗服务的患者的资料。这次洩密事件导致了大量资料遗失，受影响的组织遭到了多起诉讼。

例如，根据《HIPAA杂誌》报导，2023 年 8 月，人们发现有 2,300 万份医疗记录被洩露。在过去的 12 个月中，平均每月有 9,989,003 份医疗记录被洩露。截至 2024 年 8 月 31 日的一年中，已发生 491 起涉及 500 笔或更多记录的资料外洩事件，已知外洩记录至少有 58,668,002 则。 2024 年的平均洩漏记录规模目前为 119,487 笔记录，中位洩漏记录规模为 4,109 笔记录。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按组件截取片段
  • 影像方式片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 提高诊断准确性和效率
      • 疾病早期检测需求不断成长
    • 限制
      • 网路安全与资料安全风险
      • 人工智慧决策中的伦理与法律挑战
    • 机会
      • 新兴市场扩张
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大行销品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • 最新进展与突破
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：人工智慧影像诊断市场（按组件划分）

  • 软体
  • 硬体
  • 服务

第 6 章：人工智慧影像诊断市场（以影像方式划分）

  • 电脑断层扫描 (CT)
  • X 光影像
  • 磁振造影（MRI）
  • 超音波成像
  • 乳房X光检查
  • 正子断层扫描 (PET)
  • 其他的

第 7 章：人工智慧影像诊断市场（按应用划分）

  • 放射科
  • 心臟病学
  • 眼科
  • 肿瘤学
  • 神经病学
  • 骨科
  • 牙科
  • 其他的

第 8 章：人工智慧影像诊断市场（按最终用户划分）

  • 医院
  • 专科诊所
  • 诊断中心
  • 研究与学术机构
  • 其他的

第 9 章：人工智慧成像诊断市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • deepc GmbH
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Qure.ai Technologies Private Limited
  • DeepTek.ai, Inc
  • Koninklijke Philips NV
  • Tempus AI, Inc.
  • Rayscape
  • Infervision
  • AIKENIST
  • Rad AI
  • Brainomix Limited

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MI9418

The global AI-powered imaging diagnostics market size reached US$ 1.61 billion in 2024 and is expected to reach US$ 9.73 billion by 2033, growing at a CAGR of 22.3% during the forecast period 2025-2033.

AI-powered imaging diagnostics refers to the use of artificial intelligence (AI) technologies, such as machine learning (ML), deep learning (DL), and computer vision, to analyze, interpret, and enhance medical imaging data to aid in the diagnosis of various medical conditions. This technology applies advanced algorithms to process medical images like X-rays, CT scans, MRIs, mammograms, ultrasounds, and other imaging modalities to detect patterns, identify abnormalities, and make diagnostic predictions, often with higher accuracy and speed than traditional methods.

Market Dynamics: Drivers & Restraints

Improved diagnostic accuracy and efficiency are significantly driving the AI-powered imaging diagnostics market growth

AI systems are used to detect breast cancer in mammograms with a level of accuracy comparable to or even exceeding that of experienced radiologists. By reducing the number of false positives and false negatives, AI aids radiologists in providing a more accurate diagnosis, which is crucial for patient outcomes. The AI system identified more cancers and reduced false positives, thus improving the overall diagnostic process. Thus, major players in imaging diagnostics are focusing on AI-enabled imaging diagnostics.

For instance, in January 2025, Royal Philips, a global leader in health technology, launched the AI-enabled CT 5300. Philips CT 5300 system, equipped with advanced AI capabilities, is designed for diagnosis, interventional procedures, and screening. The flexible X-ray CT system increases diagnostic confidence, streamlines workflow efficiency, and maximizes system up-time, helping to improve patient outcomes and department productivity.

In addition to enhancing diagnostic accuracy, AI-powered imaging tools significantly improve the efficiency of the diagnostic process. AI can rapidly process medical images, delivering results faster than human radiologists. This increased efficiency benefits healthcare systems by reducing wait times, improving patient throughput, and optimizing workflows in busy clinical environments.

Cybersecurity and data security risks hampering market growth

As the AI-powered imaging diagnostics market continues to grow, there are significant concerns about cybersecurity and data security that can hinder the widespread adoption and advancement of these technologies. These risks are particularly important because AI-powered diagnostic tools depend heavily on the collection, storage, and analysis of vast amounts of sensitive patient data, including medical images, diagnostic results, and personal health information.

AI-powered imaging diagnostics systems rely on large datasets of medical images, which are often stored in cloud environments or healthcare information systems. These systems, while enabling powerful AI capabilities, also create significant vulnerabilities to data breaches and unauthorized access. The cyberattack compromised the data of patients who had used healthcare services where AI tools for imaging diagnostics were being implemented. The breach resulted in significant data loss, and multiple lawsuits were filed against the affected organizations.

For instance, according to the HIPAA Journal, in August 2023, 23 million breached healthcare records were noticed. Over the past 12 months, an average of 9,989,003 healthcare records were breached each month. In the year to August 31, 2024, there have been 491 data breaches of 500 or more records, and at least 58,668,002 records are known to have been breached. The average breach size in 2024 is currently 119,487 records, and the median breach size is 4,109 records.

Segment Analysis

The global AI-powered imaging diagnostics market is segmented based on component, imaging modality, application, end-user, and region.

Application:

The radiology from application segment is expected to dominate the AI-powered imaging diagnostics market with the highest market share

Radiology generates a vast amount of imaging data, making it a key area where AI can significantly contribute. AI can analyze large datasets of medical images quickly and accurately, identifying patterns or anomalies that may not be immediately visible to human radiologists. AI-powered tools are already demonstrating their ability to improve diagnostic accuracy and reduce errors in radiology.

For instance, in September 2024, harrison.ai launched Harrison.rad.1, a radiology-specific vision language model. It represents a major breakthrough in applying AI to tackle the global healthcare challenge. The model is now being made accessible to selected industry partners, healthcare professionals, and regulators around the world to spark collective conversations about the safe, responsible, and ethical use of AI to revolutionise healthcare access and capability and to improve patient outcomes.

AI has a significant advantage in terms of speed. AI systems can analyze images in seconds, compared to the much longer time it takes human radiologists. This helps in time-sensitive scenarios like stroke diagnosis, where the rapid assessment of imaging data can significantly impact patient outcomes. AI's ability to reduce false positives and false negatives has proven valuable in reducing diagnostic errors.

Geographical Analysis

North America is expected to hold a significant position in the global AI-powered imaging diagnostics market with the highest market share

North America is a global leader in healthcare innovation and AI research. The region is home to some of the world's top universities, research institutions, and technology companies that are pushing the boundaries of AI in healthcare. This continuous innovation ensures that North America, especially the United States, maintains its leadership position in AI healthcare technologies.

For instance, the U.S. healthcare market is one of the largest in the world, with healthcare spending grew 4.1 percent in 2022, reaching $4.5 trillion or $13,493 per person, according to the Centers for Medicare & Medicaid Services (CMS). This substantial investment supports the adoption of cutting-edge technologies like AI in medical imaging to improve diagnostic accuracy and efficiency.

North America's dominance in the AI-powered imaging diagnostics market is driven by its technological leadership, high healthcare spending, government support, and the presence of major AI and healthcare companies. The combination of advanced infrastructure, regulatory support, and robust investment in AI innovation positions North America at the forefront of the AI-powered medical imaging sector. With continued advancements in AI technology, North America is expected to remain the largest market for AI-powered diagnostic tools, significantly shaping the future of healthcare diagnostics.

Competitive Landscape

Top companies in the AI-powered imaging diagnostics market includes deepc GmbH, Qure.ai Technologies Private Limited, DeepTek.ai, Inc, Koninklijke Philips N.V., Tempus AI, Inc., Rayscape, Infervision, AIKENIST, Rad AI, Brainomix Limited, and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global AI-powered imaging diagnostics market report delivers a detailed analysis with 70 key tables, more than 60 visually impactful figures and 172 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Component
  • 2.4. Snippet by Imaging Modality
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Improved Diagnostic Accuracy and Efficiency
      • 3.1.1.2. Rising Demand for Early Detection of Diseases
    • 3.1.2. Restraints
      • 3.1.2.1. Cybersecurity and Data Security Risks
      • 3.1.2.2. Ethical and Legal Challenges in AI Decision-Making
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established Leaders with Largest Marketing Brand
    • 4.1.3. Market Leaders with Established Products
  • 4.2. Latest Developments and Breakthroughs
  • 4.3. Regulatory and Reimbursement Landscape
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. Asia Pacific
    • 4.3.4. Latin America
    • 4.3.5. Middle East & Africa
  • 4.4. Porter's Five Force Analysis
  • 4.5. Supply Chain Analysis
  • 4.6. Patent Analysis
  • 4.7. SWOT Analysis
  • 4.8. Unmet Needs and Gaps
  • 4.9. Recommended Strategies for Market Entry and Expansion
  • 4.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.11. Pricing Analysis and Price Dynamics
  • 4.12. Key Opinion Leaders

5. AI-Powered Imaging Diagnostics Market, By Component

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 5.1.2. Market Attractiveness Index, By Component
  • 5.2. Software*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Hardware
  • 5.4. Services

6. AI-Powered Imaging Diagnostics Market, By Imaging Modality

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 6.1.2. Market Attractiveness Index, By Imaging Modality
  • 6.2. Computed Tomography (CT)*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. X-Ray Imaging
  • 6.4. Magnetic Resonance Imaging (MRI)
  • 6.5. Ultrasound Imaging
  • 6.6. Mammography
  • 6.7. Positron Emission Tomography (PET)
  • 6.8. Others

7. AI-Powered Imaging Diagnostics Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Radiology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Ophthalmology
  • 7.5. Oncology
  • 7.6. Neurology
  • 7.7. Orthopedic
  • 7.8. Dentistry
  • 7.9. Others

8. AI-Powered Imaging Diagnostics Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Research & Academic Institutes
  • 8.6. Others

9. AI-Powered Imaging Diagnostics Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. UK
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. deepc GmbH*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Qure.ai Technologies Private Limited
  • 11.3. DeepTek.ai, Inc
  • 11.4. Koninklijke Philips N.V.
  • 11.5. Tempus AI, Inc.
  • 11.6. Rayscape
  • 11.7. Infervision
  • 11.8. AIKENIST
  • 11.9. Rad AI
  • 11.10. Brainomix Limited

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us